Thyrotropin-Releasing Hormone (TRH) is a naturally occurring tripeptide associated with hypothalamic signaling and the hypothalamic-pituitary-thyroid (HPT) axis. In controlled laboratory models, TRH is examined for receptor interactions and signaling events involving thyroid-stimulating hormone (TSH) pathways. Synthetic TRH provides a defined research material for in vitro analytical, biochemical, and molecular investigations.
The isolation and synthesis of TRH contributed to the early characterization of hypothalamic signaling and endocrine feedback systems. Its identification provided researchers with a defined molecule for studying peptide-receptor binding, pituitary signaling mechanisms, and structure-activity relationships under controlled experimental conditions.
Current research involving TRH focuses on receptor activity, signal transduction, peptide stability, and related molecular pathways in laboratory models. These investigations do not establish clinical safety, efficacy, diagnostic utility, or therapeutic application. For laboratory research use only. Not for human or animal consumption, veterinary use, diagnostic or therapeutic use, or use as a food, drug, cosmetic, or dietary supplement.
The primary concern for peptide researchers today is product purity. Nord-sci guarantees our product purity by performing independent testing of our products and providing those certifications for our customers in our product descriptions.
THIS PRODUCT IS NOT INTENDED TO TREAT, CURE OR DIAGNOSE ANY CONDITION OR DISEASE AND IS NOT FOR HUMAN CONSUMPTION. ALL PRODUCTS OFFERED ARE INTENDED FOR LABORATORY RESEARCH USE ONLY.
All products are produced using lyophilization (freeze-drying), a preservation method that allows peptides to remain fully stable during shipping for approximately 3-4 months. Once a peptide has been reconstituted with bacteriostatic water, it must be refrigerated to maintain integrity. After reconstitution, peptides typically remain stable for up to 30 days when stored properly.
Lyophilization, also referred to as cryodesiccation, is a specialized dehydration process in which peptides are first frozen and then exposed to a low-pressure environment. This causes the water within the vial to transition directly from a solid to a vapor (sublimation), leaving behind a dry, crystalline white material known as a lyophilized peptide. In this powdered form, peptides may be safely stored at room temperature until they are ready to be reconstituted with bacteriostatic water.
After delivery, peptides should be protected from heat and light. If use is expected within the near future (whether days, weeks, or a few months) refrigerated storage below 4°C (39°F) is generally sufficient. Lyophilized peptides are commonly stable at room temperature for several weeks or longer, making short-term ambient storage acceptable when use is anticipated within that timeframe.
For extended storage, ranging from several months to multiple years, freezing is strongly recommended. Storage at -80°C (-112°F) offers optimal long-term stability and helps preserve peptide structure and quality over time.
For more detailed guidance on peptide handling and storage best practices, please refer to the resource below:
TRH Thyrotropin is a synthetic tripeptide supplied as a lyophilized powder in 20mg and 50mg vial formats. It is intended exclusively for controlled laboratory research, analytical evaluation, and in vitro experimentation.
For laboratory research use only. Not for human or animal consumption.
TRH Thyrotropin – Research Specifications:
| Active Compound | TRH (thyrotropin-releasing hormone), also known as protirelin |
| Sequence | pGlu-His-Pro-NH₂ |
| Molecular Formula | C₁₆H₂₂N₆O₄ |
| Molecular Weight | 362.38 g/mol |
| CAS Number | 24305-27-9 |
| Source | Chemical synthesis |
| Format | Lyophilized powder |
| Available Quantities | 20mg or 50mg, as labeled |
| Purity and Identity | Refer to the lot-specific Certificate of Analysis |
| Storage Conditions | Store sealed in a cool, dry environment protected from heat, light, and moisture. Follow the applicable COA and laboratory SOPs. |
| Documentation | Lot-specific analytical documentation is available through the COA Library |
| Research Use Only | Not for human consumption, veterinary use, clinical use, or in vivo procedures |
The molecular formula, molecular weight, sequence, and registry information correspond to the identified TRH compound listed by PubChem and ChEBI.
TRH, or thyrotropin-releasing hormone, is a tripeptide composed of pyroglutamyl, histidyl, and prolinamide residues. Its compact and well-characterized structure makes it suitable for controlled laboratory investigations involving peptide identification, analytical separation, receptor-interaction models, and signaling-pathway characterization.
Within research environments, TRH may be used as a reference analyte or experimental reagent in studies examining ligand-receptor interactions, time-dependent signaling measurements, peptide stability, degradation pathways, and assay performance. Published analytical research has also described liquid chromatography and mass spectrometry methods for identifying and quantifying TRH in complex research samples.
This information describes the compound’s chemical identity and laboratory research context only. It does not provide dosing, preparation, administration, clinical, diagnostic, or therapeutic guidance.
Important Research Notice: Nordsci products are supported by lot-specific analytical documentation. Researchers should review the applicable Certificate of Analysis before incorporating a material into an experimental protocol.
THIS PRODUCT IS INTENDED EXCLUSIVELY FOR LABORATORY RESEARCH USE. NOT FOR HUMAN OR ANIMAL CONSUMPTION. NOT FOR CLINICAL, DIAGNOSTIC, THERAPEUTIC, VETERINARY, FOOD, COSMETIC, OR SUPPLEMENT USE.
TRH may be incorporated into controlled in vitro models examining ligand-receptor interactions and signaling measurements associated with established TRH pathways. Experimental endpoints should be defined in advance and evaluated using validated analytical methods.
Researchers may use TRH in laboratory models designed to examine time-dependent signaling patterns, feedback-system architecture, and changes in measurable assay outputs. Environmental conditions, sampling intervals, controls, and analytical procedures should remain standardized throughout the study.
TRH may be evaluated in biochemical, cellular, or receptor-based systems examining interactions among defined signaling pathways. These studies require appropriate controls and clearly separated experimental variables to support interpretable results.
In studies containing multiple research inputs, TRH should be evaluated within a documented experimental framework. Researchers should establish primary endpoints, control groups, sampling schedules, and acceptance criteria before beginning the protocol. Each compound should be assessed independently when necessary to distinguish compound-specific analytical responses.
TRH Thyrotropin should be handled only by qualified laboratory personnel in appropriately equipped research facilities. Maintain the vial in its original sealed container and protect the material from heat, light, moisture, contamination, and unnecessary environmental exposure.
Use appropriate personal protective equipment and follow the applicable Safety Data Sheet, Certificate of Analysis, institutional requirements, and laboratory SOPs. Maintain records for lot identification, receipt date, storage conditions, transfers, and experimental allocation.
Do not use this product in humans or animals. No dosing, administration, application, or preparation instructions are provided.
Lot-specific Certificates of Analysis are available to support material identification, internal quality review, procurement records, and study documentation. The applicable COA should be reviewed for reported purity, identity, analytical methods, and batch-specific results.
Access available documentation through the Nordsci COA Library.
COA results apply only to the lot identified on the corresponding document and should not be generalized across separate production lots.
Laboratories sourcing TRH Thyrotropin should prioritize accurate labeling, lot traceability, defined storage requirements, and accessible analytical documentation. Nordsci Peptides supplies TRH Thyrotropin in labeled 20mg and 50mg formats with lot-specific documentation available for research procurement and recordkeeping.
IMPORTANT: TRH Thyrotropin is sold exclusively as a laboratory research material. It is not a drug, dietary supplement, food, cosmetic, medical device, or veterinary product. Purchasers are responsible for compliance with applicable laws, institutional policies, and laboratory requirements.
